The regulator told states not to demand USFDA or EU approvals in tenders after complaints that Indian-made devices were being sidelined
Pune-based Biorad Medisys is developing an implantable vagus nerve stimulation device that aims to improve insulin balance, regulate hunger, and support obesity care without drugs or chemical compound
The transaction underscores Inviga's commitment to supporting world-class, AI-driven diagnostic solutions conceived and built in India for global scale
Draft guidelines aim to align India's medtech software framework with global practices; industry seeks more clarity on AI/ML evaluation and algorithm change management
The ministry has issued a draft notification proposing an amendment to add qualifications for inspectors and government analysts under Rule 18 of the Medical Device Rules (MDR), 2017
The NPPA has extended the ceiling price for knee implants till November 2025 while considering industry pleas for removal, citing rising costs and supply chain issues
Industry body Aimed says proposed balanced reforms could help reduce healthcare costs for consumers
Industry bodies asked the govt for a three-month transition period, use of old packaging, and a simpler GST refund mechanism to avoid supply chain disruptions in healthcare
GST rationalisation lowers costs for medical consumables and high-end therapies, benefiting patients. However, pharma companies, particularly in biologics, may face margin pressure due to ITC loss
GST reduction on medical devices, diagnostic kits, and reagents is a welcome move, but leading diagnostic players believe test prices will remain largely unaffected due to minimal changes
GST Council meet outcome: GST on various medical apparatus and devices used for medical, surgical, dental or veterinary usage has been reduced to 5% from 12%
Imports should be restricted to original manufacturers or certified partners, while devices that are too old or have exceeded usage thresholds should be barred
AIMED said GST changes could hurt domestic medtech competitiveness and tilt the market towards imports, urging balanced tax slabs, refund reforms, and a higher Health Cess
A high-level inter-departmental committee has begun discussions on regulating refurbished medical devices, balancing patient safety concerns with affordable healthcare access
Medical device companies raise issues with the DoP over UDMPMD norms related to disclosure of training expenses and restrictions on overseas training approvals
Medical device makers can now outsource sterilisation through third-party agreements without loan licences if the facility holds a valid sterilisation licence
Renalyx Health Systems launches AI-enabled dialysis machine RxT21 with real-time monitoring at ₹6.7 lakh, plans to scale production and expand into global markets
The move comes after the EU, in its investigation, found that Beijing discriminated against foreign firms in procurement of medical devices
Technology Development Board to fund S3V Vascular Technologies for manufacturing India's first thrombectomy device, aiming to reduce import dependency and boost stroke care
The company says that the new device is more compact and easier to use than its predecessor